Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT06671873 | Study on Mass Balance of [14C]HMPL-306（Isocitrate Dehydrogenase Inhibitor） in Healthy Chinese Adult Male Subjects | PHASE1 | COMPLETED | 6 | — | — | Nov 1, 2024 | Jul 1, 2025 | Jul 30, 2025 | - | — |
| Name | Type | Description |
|---|---|---|
| 100 µCi [14C] HMPL-306 | DRUG | D1: 250 mg/100 µCi \[14C\] HMPL-306 Single dose |